Search engine finds info for practicing physicians

Share this article:
Pharma marketers now have an added opportunity to connect with healthcare professionals with the debut of an innovative search engine designed by CMPMedica.

The new site, at SearchMedica.com, will offer vertical or topic-specific search engines for doctors and other health professionals. Unbiased search results will contain well-known journals, peer-reviewed research and articles for healthcare professionals.

At press time, the site was in its first phase of roll-out, offering  search capabilities specializing in psychiatry.

Similar search engines focused on primary care, oncology and other specialties will debut in 2007, CMPMedica's senior product manager Cyndy Finnie told MM&M.

“While Google goes out and crawls all of the Internet, SearchMedica.com crawls the Web sites that are of most interest to practicing doctors.” Finnie explained.

The site is free and available to all healthcare professionals and will be supported by ads, offering opportunities to marketers seeking to reach a health professional audience, Finnie said.

“We are using a hybrid model that's a combination of sponsorship and performance,” she said. “So, for example, a pharmaceutical company has the opportunity to own a category or therapeutic area exclusively or share the real estate.”

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...